Urology · North Little Rock, AR
NPI
1891760583
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3320 Springhill Dr
North Little Rock, AR, 72117
Phone (501) 906-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$364K
10,960 services
Medicare patients, 2024
1,236
Average age 75
Drug cost, 2024
$1.7M
2,370 prescriptions
Company payments, 2025
$6,587
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ronald G Kuhn was code J0897 (injection, denosumab, 1 mg), 1,860 times for 14 patients. In total Ronald G Kuhn billed 10,960 services in 126 codes, and Medicare paid $364K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,860 | 14 | $20.93 | $39K |
| 36415 Venipuncture Blood Collection | Office | 1,636 | 912 | $8.64 | $14K |
| 81003 Clinical Chemistry | Office | 1,446 | 966 | $2.19 | $3,165 |
| 84153 Clinical Chemistry | Office | 937 | 652 | $17.97 | $17K |
| 99214 Office E&M - Established | Office | 848 | 657 | $85.88 | $73K |
| 99213 Office E&M - Established | Office | 424 | 381 | $54.60 | $23K |
| 51798 Ultrasound - Nonspecific | Office | 304 | 263 | $7.04 | $2,141 |
| 85025 Blood Count | Office | 222 | 127 | $7.59 | $1,686 |
| 52000 Cystourethroscopy | Office | 167 | 141 | $161.12 | $27K |
| 82565 Clinical Chemistry | Office | 149 | 129 | $5.02 | $748 |
| 80053 Clinical Chemistry | Office | 127 | 74 | $10.35 | $1,314 |
| 80048 Clinical Chemistry | Office | 116 | 93 | $8.16 | $947 |
| 99215 Office E&M - Established | Office | 116 | 107 | $114.79 | $13K |
| 99203 Office E&M - New | Office | 88 | 88 | $71.35 | $6,279 |
| 82310 Clinical Chemistry | Office | 76 | 69 | $5.06 | $385 |
By year: 2022 $1.1M for 31,286 services; 2023 $739K for 17,730 services; 2024 $364K for 10,960 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,636 | 912 | $8.64 | $14K |
| 81003 Clinical Chemistry | 1,446 | 966 | $2.19 | $3,165 |
| 84153 Clinical Chemistry | 937 | 652 | $17.97 | $17K |
| 85025 Blood Count | 222 | 127 | $7.59 | $1,686 |
| 82565 Clinical Chemistry | 149 | 129 | $5.02 | $748 |
| 80053 Clinical Chemistry | 127 | 74 | $10.35 | $1,314 |
| 80048 Clinical Chemistry | 116 | 93 | $8.16 | $947 |
| 82310 Clinical Chemistry | 76 | 69 | $5.06 | $385 |
| 80076 Clinical Chemistry | 58 | 55 | $8.01 | $465 |
| 82306 Clinical Chemistry | 29 | 24 | $29.01 | $841 |
Medicare prescription drug claims, 2024
In 2024, the drug Ronald G Kuhn prescribed most often to Medicare patients was Tamsulosin Hcl, with 649 prescriptions and refills. In total Ronald G Kuhn wrote 2,370 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 649 | 1,523 | 265 | $13K |
| Finasteride Generic | 422 | 971 | 152 | $5,140 |
| Ciprofloxacin Hcl Generic | 136 | 136 | 112 | $420 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 130 | 130 | 114 | $348 |
| Levofloxacin Generic | 111 | 111 | 100 | $283 |
| Orgovyx Relugolix | 100 | 100 | 22 | $261K |
| Ondansetron Odt Ondansetron | 80 | 80 | 78 | $361 |
| Xtandi Enzalutamide | 71 | 71 | 12 | $898K |
| Gemtesa Vibegron | 58 | 82 | 18 | $38K |
| Dutasteride Generic | 42 | 112 | 21 | $1,529 |
| Cephalexin Generic | 38 | 40 | 36 | $155 |
| Myrbetriq Mirabegron | 31 | 31 | Under 11 | $13K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 30 | 32 | 20 | $388 |
| Silodosin Generic | 24 | 36 | Under 11 | $945 |
| Potassium Citrate Er Potassium Citrate | 23 | 31 | Under 11 | $1,744 |
Brand drugs: - claims; generic drugs: 2,021 claims; opioid claims: 156.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ronald G Kuhn $6,587 ($6,587 in general payments such as food, travel and fees) from 7 companies. The largest payer was AngioDynamics, Inc. with $6,167.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.